Omnicell, Inc. (OMCL)
Company Description
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally.
The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.
It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software.
In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings.
Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001.
Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
Country | United States |
Founded | 1992 |
IPO Date | Aug 7, 2001 |
Industry | Health Information Services |
Sector | Healthcare |
Employees | 3,650 |
CEO | Randall A. Lipps |
Contact Details
Address: 4220 North Freeway Fort Worth, Texas 76137 United States | |
Phone | (877) 415-9990 |
Website | omnicell.com |
Stock Details
Ticker Symbol | OMCL |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0000926326 |
CUSIP Number | 68213N109 |
ISIN Number | US68213N1090 |
Employer ID | 94-3166458 |
SIC Code | 3571 |
Key Executives
Name | Position |
---|---|
Randall A. Lipps | Founder, Executive Chairman, President and Chief Executive Officer |
Corey J. Manley | Executive Vice President and Chief Legal and Administrative Officer |
Nchacha Etta | Executive Vice President and Chief Financial Officer |
Minoo Mortazavi | Senior Vice President of Global Operations |
Brian H. Nutt | Vice President, Chief Accounting Officer and Corporate Controller |
Giri Chodavarapu | Senior Vice President and Chief Information Officer |
Kathleen Nemeth | Senior Vice President of Investor Relations |
Maximo Rocha | Senior Vice President and Chief People Officer |
Joseph Brian Spears | Executive Adviser |
Sara Dalmasso | Senior Vice President and GM of International |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Feb 29, 2024 | 8-K | Current Report |
Feb 28, 2024 | 10-K | Annual Report |
Feb 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Feb 8, 2024 | 8-K | Current Report |
Jan 19, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Jan 11, 2024 | 8-K | Current Report |
Dec 11, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Nov 9, 2023 | 8-K | Current Report |
Nov 3, 2023 | 10-Q | Quarterly Report |
Nov 2, 2023 | 8-K | Current Report |